Actively Recruiting
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
Led by MGH Institute of Health Professions · Updated on 2024-08-01
30
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the study are: * To compare 8-week supervised maintenance program delivered onsite and via tele-rehab with no maintenance for patients with Chronic Lung Disease following discharge from traditional exercise or physical therapy or onsite outpatient rehabilitation programs on clinical outcomes (dyspnea, exercise capacity, physical function, physical activity, and quality of life) at 8 weeks and 4-months post-intervention. * To compare the differences in dyspnea, exercise capacity, physical function, physical activity, and quality of life between an 8-week maintenance program delivered onsite and via tele-rehab at 8-weeks and 4-months post-intervention in patients with Chronic Lung Disease following discharge from traditional onsite outpatient rehabilitation. Participants in both intervention groups (onsite and tele-rehab) will undergo a baseline onsite assessment followed by an 8-week supervised exercise intervention either onsite or in a telehealth setting. Control group will receive biweekly check in calls, but no active intervention.
CONDITIONS
Official Title
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 40 years and older with physician diagnosed Chronic Lung Disease within 2 months of discharge following completion of traditional onsite outpatient rehabilitation, physical therapy, or exercise program
- Able to walk independently with or without mobility devices
- Able to complete a six-minute walk test at discharge with or without supplemental oxygen maintaining oxygen saturation at or above 85%
- Able to follow commands and instructions in English
- Have ability to connect to the internet
You will not qualify if you...
- Significant mobility limitations such as history of stroke, Parkinson's disease, relapsing multiple sclerosis, significant degenerative osteoarthritis, or other joint impairments compromising independent walking
- Primarily rely on a wheelchair for mobility
- Unable to complete a walking test without oxygen saturation dropping below 85% at discharge
- Baseline hemodynamic compromise, unstable angina, recent myocardial infarction within a week, uncontrollable atrial fibrillation not managed with medications, advanced heart failure (NYHA class 4), or mechanical circulatory assist devices such as ventricular assist devices
- Inability to communicate in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MGH Institute of Health Professions
Charlestown, Massachusetts, United States, 02129
Actively Recruiting
Research Team
S
Shweta Gore, PhD
CONTACT
J
Jane Baldwin, DPT
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here